Alfresa Holdings Corporation (TYO: 2784)

Market Cap	419.88B
Revenue (ttm)	2.89T
Net Income (ttm)	31.77B
Shares Out	186.90M
EPS (ttm)	169.97
PE Ratio	13.22
Forward PE	13.97
Dividend	64.00 (2.86%)
Ex-Dividend Date	Mar 28, 2025

Volume	572,900
Open	2,207.00
Previous Close	2,203.00
Day's Range	2,204.00 - 2,255.50
52-Week Range	1,929.00 - 2,551.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,517
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2023, Alfresa Holdings's revenue was 2.86 trillion, an increase of 6.02% compared to the previous year's 2.70 trillion. Earnings were 29.56 billion, an increase of 14.63%.